CO6821957A2 - Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives - Google Patents
Solid forms and salts of tetrahydro-pyrido-pyrimidine derivativesInfo
- Publication number
- CO6821957A2 CO6821957A2 CO13291228A CO13291228A CO6821957A2 CO 6821957 A2 CO6821957 A2 CO 6821957A2 CO 13291228 A CO13291228 A CO 13291228A CO 13291228 A CO13291228 A CO 13291228A CO 6821957 A2 CO6821957 A2 CO 6821957A2
- Authority
- CO
- Colombia
- Prior art keywords
- pyrido
- tetrahydro
- salts
- solid forms
- pyrimidine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IR1390040156 | 2011-06-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6821957A2 true CO6821957A2 (en) | 2013-12-31 |
Family
ID=50231547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO13291228A CO6821957A2 (en) | 2011-06-27 | 2013-12-12 | Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP2723740A1 (en) |
JP (1) | JP2014518256A (en) |
KR (1) | KR20140025530A (en) |
CN (1) | CN103608349A (en) |
AU (1) | AU2012277391A1 (en) |
CA (1) | CA2840315A1 (en) |
CL (1) | CL2013003567A1 (en) |
CO (1) | CO6821957A2 (en) |
EA (1) | EA201490164A1 (en) |
MA (1) | MA35203B1 (en) |
MX (1) | MX2013015001A (en) |
SG (1) | SG195067A1 (en) |
TN (1) | TN2013000483A1 (en) |
WO (1) | WO2013001445A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2742940B1 (en) | 2012-12-13 | 2017-07-26 | IP Gesellschaft für Management mbH | Fumarate salt of (R)-3-(6-(4-methylphenyl)-pyridin-3-yloxy)-l-aza-bicyclo-[2.2.2]octane for adminstration once daily, twice daily or thrice daily |
CN104945367A (en) * | 2015-06-04 | 2015-09-30 | 聂超 | Benzaldehyde propylene glycolacetal and preparation method thereof |
JP7132123B2 (en) * | 2016-02-10 | 2022-09-06 | ノバルティス アーゲー | Use of an active or functional inhibitor of PI3K for the treatment of primary Sjögren's syndrome |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1524747A (en) | 1976-05-11 | 1978-09-13 | Ici Ltd | Polypeptide |
LU88769I2 (en) | 1982-07-23 | 1996-11-05 | Zeneca Ltd | Bicalutamide and its pharmaceutically acceptable salts and esters (Casodex (R)) |
GB8327256D0 (en) | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
US5093330A (en) | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
US5010099A (en) | 1989-08-11 | 1991-04-23 | Harbor Branch Oceanographic Institution, Inc. | Discodermolide compounds, compositions containing same and method of preparation and use |
NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
AU661533B2 (en) | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
TW225528B (en) | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
GB9314893D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
EP2295415A1 (en) | 1995-03-30 | 2011-03-16 | OSI Pharmaceuticals, Inc. | Quinazoline derivatives |
GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
US5843901A (en) | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
SI9620103A (en) | 1995-07-06 | 1998-10-31 | Novartis Ag | Pyrrolopyrimidines and processes for the preparation thereof |
US5760041A (en) | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
PL190489B1 (en) | 1996-04-12 | 2005-12-30 | Warner Lambert Co | Irreversible inhibitors of tyrosine kinases |
EP0907642B1 (en) | 1996-06-24 | 2005-11-02 | Pfizer Inc. | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases |
WO1998008849A1 (en) | 1996-08-30 | 1998-03-05 | Novartis Aktiengesellschaft | Method for producing epothilones, and intermediate products obtained during the production process |
CA2264908C (en) | 1996-09-06 | 2006-04-25 | Obducat Ab | Method for anisotropic etching of structures in conducting materials |
CA2265630A1 (en) | 1996-09-13 | 1998-03-19 | Gerald Mcmahon | Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders |
EP0837063A1 (en) | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazoline derivatives |
DE59712968D1 (en) | 1996-11-18 | 2008-10-30 | Biotechnolog Forschung Gmbh | Epothilones E and F |
US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
CO4940418A1 (en) | 1997-07-18 | 2000-07-24 | Novartis Ag | MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL-2-PIRIMIDINAMINE, PROCESSES FOR ITS MANUFACTURE AND USE |
GB9721069D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Polymeric derivatives of camptothecin |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
JP2002504540A (en) | 1998-02-25 | 2002-02-12 | スローン−ケッタリング インスティトゥート フォア キャンサー リサーチ | Synthesis of epothilone, its intermediates and analogs |
ATE459616T1 (en) | 1998-08-11 | 2010-03-15 | Novartis Ag | ISOCHINOLINE DERIVATIVES WITH ANGIOGENESIS-INHIBITING EFFECT |
KR100716272B1 (en) | 1998-11-20 | 2007-05-09 | 코산 바이오사이언시즈, 인코포레이티드 | Recombinant methods and materials for producing epothilone and epothilone derivatives |
PE20020354A1 (en) | 2000-09-01 | 2002-06-12 | Novartis Ag | HYDROXAMATE COMPOUNDS AS HISTONE-DESACETILASE (HDA) INHIBITORS |
KR20080014934A (en) | 2000-11-07 | 2008-02-14 | 노파르티스 아게 | Indolylmaleimide derivatives as protein kinase c inhibitors |
AR035885A1 (en) | 2001-05-14 | 2004-07-21 | Novartis Ag | DERIVATIVES OF 4-AMINO-5-FENIL-7-CYCLLOBUTILPIRROLO (2,3-D) PYRIMIDINE, A PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION AND THE USE OF SUCH DERIVATIVES FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION |
GB0119249D0 (en) | 2001-08-07 | 2001-10-03 | Novartis Ag | Organic compounds |
AR039209A1 (en) | 2002-04-03 | 2005-02-09 | Novartis Ag | INDOLILMALEIMIDA DERIVATIVES |
AU2003297740B2 (en) | 2002-12-09 | 2008-09-11 | The Board Of Regents Of The University Of Texas System | Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3) |
CA2545427C (en) | 2004-01-12 | 2012-08-21 | Cytopia Research Pty Ltd | Selective kinase inhibitors |
JP5498374B2 (en) * | 2007-04-17 | 2014-05-21 | エボテック・アーゲー | 2-Cyanophenyl fused heterocyclic compounds and compositions and uses thereof |
UA112517C2 (en) | 2010-07-06 | 2016-09-26 | Новартіс Аг | TETRAHYDROPYRIDOPYRIMIDINE DERIVATIVES |
-
2012
- 2012-06-25 EP EP12738616.7A patent/EP2723740A1/en not_active Withdrawn
- 2012-06-25 CN CN201280030091.2A patent/CN103608349A/en not_active Withdrawn
- 2012-06-25 KR KR1020137034120A patent/KR20140025530A/en not_active Application Discontinuation
- 2012-06-25 EA EA201490164A patent/EA201490164A1/en unknown
- 2012-06-25 AU AU2012277391A patent/AU2012277391A1/en not_active Abandoned
- 2012-06-25 SG SG2013085923A patent/SG195067A1/en unknown
- 2012-06-25 MX MX2013015001A patent/MX2013015001A/en not_active Application Discontinuation
- 2012-06-25 JP JP2014518016A patent/JP2014518256A/en not_active Withdrawn
- 2012-06-25 WO PCT/IB2012/053209 patent/WO2013001445A1/en active Application Filing
- 2012-06-25 CA CA2840315A patent/CA2840315A1/en not_active Withdrawn
-
2013
- 2013-11-19 TN TNP2013000483A patent/TN2013000483A1/en unknown
- 2013-12-12 CL CL2013003567A patent/CL2013003567A1/en unknown
- 2013-12-12 CO CO13291228A patent/CO6821957A2/en not_active Application Discontinuation
- 2013-12-20 MA MA36600A patent/MA35203B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2013001445A1 (en) | 2013-01-03 |
AU2012277391A1 (en) | 2013-12-19 |
JP2014518256A (en) | 2014-07-28 |
CL2013003567A1 (en) | 2014-08-08 |
EP2723740A1 (en) | 2014-04-30 |
SG195067A1 (en) | 2013-12-30 |
MX2013015001A (en) | 2014-03-31 |
CA2840315A1 (en) | 2013-01-03 |
KR20140025530A (en) | 2014-03-04 |
TN2013000483A1 (en) | 2015-03-30 |
MA35203B1 (en) | 2014-06-02 |
CN103608349A (en) | 2014-02-26 |
EA201490164A1 (en) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201600108B (en) | PIRAZOCHINOLIN DERIVATIVES AS INHIBITORS OF PDE9 | |
CO6821892A2 (en) | Anti-angptl3 antibodies and uses thereof | |
CO6940412A2 (en) | Inhibitors of influenza virus replication | |
DK2782570T3 (en) | HETEROCYCLIC INHIBITORS OF GLUTAMINASE | |
DK3235812T3 (en) | DEUTERATED DERIVATIVES OF IVACAFTOR | |
DK2920168T3 (en) | HETEROCYCLIC GLUTAMINASE INHIBITORS | |
CO6890099A2 (en) | New dihydroquinoline-2-one derivatives | |
CO7030961A2 (en) | Benzothienyl-pyrrolotriazines and their uses | |
SMT201600153B (en) | DERIVATIVE OF AZOLO | |
CO7010824A2 (en) | Inhibitors of viral application | |
BR112013019509A2 (en) | heterocyclic derivatives | |
CO6920296A2 (en) | New bicyclic derivatives of dihydroisoquinolin-1-one | |
CO6990717A2 (en) | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | |
CO6870035A2 (en) | New bicyclic derivatives of dihydroquinoline-2-one | |
CO6900135A2 (en) | Prodrugs of methylphenidate, manufacturing processes and their use | |
AR092198A1 (en) | DERIVATIVES OF PIRAZOLOPIRIMIDINAS | |
CO7020907A2 (en) | Quinurenine-3-monooxygenase inhibitors, pharmaceutical compositions and methods of use thereof | |
DK2646452T3 (en) | CHLORATION OF CARBOHYDRATE AND CARBOHYDRATE DERIVATIVES | |
CO6811866A2 (en) | Substituted benzamide derivatives | |
ITTO20110778A1 (en) | ASYMMETRIC DYES AND THEIR USES | |
DE112011105163T8 (en) | Turbulators | |
CO6862154A2 (en) | Trans-clomiphene metabolites and uses thereof | |
BR112014012583A2 (en) | 2-iodoimidazole derivatives | |
DK2875016T3 (en) | Carbamate / urea derivatives | |
CO7020910A2 (en) | Adamantane aza derivatives and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |